Stay updated on PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.

Latest updates to the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the notices for government funding lapse and Revision: v3.4.1 were removed. These updates are routine and do not alter the study content.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding and operations notice is now displayed on the page, and the revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and a new 'Last Update Submitted that Met QC Criteria' field, along with a revision label 'Revision: v3.4.0'. Minor capitalization changes to the 'No FEAR Act data' label were also made; these are UI metadata updates that do not affect study content.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study locations were expanded to include numerous new sites across the U.S. and internationally, and several location groupings were removed.SummaryDifference2%

- Check91 days agoChange DetectedPublications section now states that items are automatically populated from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.